Abstract
Stereotactic radiosurgery with the Gamma Knife allows the delivery of focused radiation in a single session from a Cobalt-60 source to a pituitary tumor with little radiation to surrounding normal brain tissue. At this time the major role for Gamma Knife radiosurgery in acromegaly is for the treatment of failed pituitary surgery although it may also by used as primary treatment for patients unwilling or unsuitable, for medical reasons, to undergo transsphenoidal surgery. The major risk from Gamma Knife radiosurgery appears to be radiation damage to the visual pathways, but this can be obviated by limiting the radiation dose to the optic chiasm under 10 Gy. In contrast, the neuronal and vascular structures running in the cavernous sinus are much less radiosensitive allowing an ablative dose to be administered to tumors showing lateral invasion and impinging on cranial nerves III, IV, V and VI. Gamma Knife radiosurgery appears to produce effects in GH secreting tumors faster than with fractionated radiotherapy without the potential long-term risk of developing a second extrapituitary brain tumor as well as the neuropsychiatric effects associated with conventional radiation administration.
Similar content being viewed by others
References
Abosch A. Tyrrell JB, Lamborn KR, DDHannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgery for growth-hormone secreting pituitary adenomas: Initial outcome and long-term results. J Clin Endocrinol Metab 1998;83:3411–3418.
Swearingen B, Barker II FG, Katznelson L, et al. Longterm mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419–3426.
Melmed S. Editorial: Tight control of growth hormone: An attainable outcome for acromegaly treatment. J Clin Endocrinol Metab 1998;83:3409–3410.
Melmed S. Acromegaly. N Engl J Med 1990;322:966–977.
Newman CB, Melmed S, George A, Torigian D, Duhanney M, Snyder P, Young W, Klibanski A, Molitch M, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg D. Octreotide as Primary Therapy for Acromegaly. J Clin Endocrinol Metab 1998; 83:3034–3040.
Melmed S, Jackson I, Kleinberg D, Klibanski A. Current Treatment Guidelines for Acromegaly. J Clin Endocrinol Metab 1998;83:2646–2652.
Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, DeMott Friberg R, ChandlerWF, Sandler HM. Pituitary radiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 1997;82:3187–3191.
van der Lely AJ, de Herder WW, Lamberts SWJ. The role of radiotherapy in acromegaly. J Clin Endocrinol Metab 1997;82:3185–3186.
Witt JC, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for pituitary tumors. In Kondziolka D, ed. Radiosurgery 1995. Basel: Karger, 1996;55–65.
Littley MD, Shalet SM, Beardwell CG, Ahmed Sr, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 1989; 70:145–160.
Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS. Glioma arising after radiation therapy for pituitary adenoma. Cancer 1993;72:2227–2233.
Loeffler JS. Comments. Neurosurgery 1998;42:178–179.
Gorden P, Glatstein E, Old~eld E, Roth J. Radiation therapy of acromegaly. In Robbins RJ, Melmed S, eds. Acromegaly. New York: Plenum Press, 1986;211–220.
Eastman RC, Gorden P, Glatstein E, Roth J. Radiation therapy of acromegaly. Endocrinol Metab Clin North Am 1992;21:693–712.
Jones B, Samarasekara S, Tan LT, Mayles WP. The influence of air cavities on the optic chiasm dose during pituitary radiotherapy for acromegaly. Br J Radiol 1996;69:723–725.
Dowsett RJ, Fowble B, Sergott RC, Savino PJ, Bosley TM, Snyder PJ, Gennarelli TA. Results of radiotherapy in the treatment of acromegaly: Lack of opthalmologic complications. Int J Radiat Oncol Biol Phys 1990;19:453–459.
Movsas B, Movsas TZ, Steinberg SM, Okunieff P. Long-term visual changes following pituitary irradiation. Int J Radiat Oncol Biol Phys 1995;33:599–605.
Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;1102:316–319.
Yoon SC, Suh TS, Jang HS, Chung SM, Kim YS, Ryu MR, Choi KH, Son HY, Kim MC, Shinn KS. Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1998;41:849–853.
Kliman B, Kjellberg RM, Swisher B, ButlerW. Proton beam therapy of acromegaly: A 20 year experience. In McL Black P, Zervas N T, Ridgway EC, Martin JB, eds. Secretory Tumours of the Pituitary Gland. Progr Endocrin Res Ther 1984;1:191–211.
Thoren M, Rahn T, Guo WY, Werner S. Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumors. Neurosurgery 1991;29:663–668.
Ganz JC, Gamma Knife treatment of pituitary adenomas. Stereotact Funct Neurosurg 1995;64:3–10.
Ganz JC, Backlund EO, Thorsen FA. The effects of gamma knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact Funct Neurosurg 1993;61:30–37.
Girkin CA, Comey CH, Lunsford LD, Goodman JL, Kline LB. Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology 1997;104:1634–1643.
Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander E 3rd, Kooy HM, Flickinger JC. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 1993;27:215–221.
Ikeda H, Jokura H, Yoshimoto T. Gamma knife radiosurgery for pituitary adenomas: Usefulness of combined transsphenoidal and gamma knife radiosurgery for adenomas invading the cavernous sinus. Radiation Oncol Invest 1998;6:26–34.
Marks LB. Conventional fractionated radiation therapy vs. radiosurgery. J Neurooncol 1993;17:223–230.
Motti ED, Losa M, Pieralli S, Aecchinelli A, Longobardi B, Giugni E, Ventrella L. Stereotactic radiosurgery of pituitary adenomas. Metab Clin & Exper 1996;45:111–114.
Stephanian E, Lunsford LD, Coffey RJ, Bissonette DJ, Flickinger JC. Gamma knife surgery for sellar and suprasellar tumors. Neurosurg Clin N Am 1992;3:207–218.
Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G. Stereotactic radiosurgery for recurrent surgically treated acromegaly: Comparison with fractionated radiotherapy. J Neurosurg 1998;88:1002–1008.
Park YG, Chang JW, Kim EY, Chung SS. Gamma knife surgery in pituitary microadenomas. Yonsei Med J 1996; 37:165–173.
Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for pituitary adenomas: Imaging, visual and endocrine results. Acta Neurochir 1994;62: 333–338.
Rocher FP, Sentenac I, Berger C, Marquis I, Romestaing P, Gerard JP. Stereotactic radiosurgery: The Lyon experience. Acta Neurochir 1995;63:109–114.
Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, Rajan B, Traish D. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. Br Med J 1992;304:1343–1346.
Simmons NE, Laws ER Jr. Glioma occurrence after sellar irradiation: Case report and review. Neurosurgery 1998;42: 172–178.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jackson, I.D., Noren, G. Role of Gamma Knife Radiosurgery in Acromegaly. Pituitary 2, 71–77 (1999). https://doi.org/10.1023/A:1009926122406
Issue Date:
DOI: https://doi.org/10.1023/A:1009926122406